Artificial Intelligence and liver: Opportunities and barriers
Clara Balsano,Patrizia Burra,Christophe Duvoux,Anna Alisi,Fabio Piscaglia,Alessio Gerussi,Interest Group Artificial Intelligence and Liver Disease; Italian Association for the Study of Liver,Maurizia Rossana Brunetto,Ferruccio Bonino,Roberto Montalti,Silvia Campanile,Marcello Persico,Domenico Alvaro,Silvano Santini,Pietro Invernizzi,Marco Carbone,Mario Masarone,Albino Eccher,Bruno Siciliano,Mario Vento,Fanny Ficuciello,Federico Cabitza,Simone Penasa,Piergiorgio Donatelli
DOI: https://doi.org/10.1016/j.dld.2023.08.048
IF: 5.165
2023-09-01
Digestive and Liver Disease
Abstract:Artificial Intelligence (AI) has recently been shown as an excellent tool for the study of the liver; however, many obstacles still have to be overcome for the digitalization of real-world hepatology. The authors present an overview of the current state of the art on the use of innovative technologies in different areas (big data, translational hepatology, imaging, and transplant setting). In clinical practice, physicians must integrate a vast array of data modalities (medical history, clinical data, laboratory tests, imaging, and pathology slides) to achieve a diagnostic or therapeutic decision. Unfortunately, machine learning and deep learning are still far from really supporting clinicians in real life. In fact, the accuracy of any technological support has no value in medicine without the support of clinicians. To make better use of new technologies, it is essential to improve clinicians' knowledge about them. To this end, the authors propose that collaborative networks for multidisciplinary approaches will improve the rapid implementation of AI systems for developing disease-customized AI-powered clinical decision support tools. The authors also discuss ethical, educational, and legal challenges that must be overcome to build robust bridges and deploy potentially effective AI in real-world clinical settings.
gastroenterology & hepatology